In previous studies, miR-137 was showed to be downregulated in human glioma tissues, which acted as a tumor suppressor to inhibit tumor growth and angiogenesis by directly targeting EZH2, EGFR, PTP4A3 (26–28). Here, EGFR is linked to neoplasm.